Prognostic relevance of cytogenetic subgroups in 357 patients with myelodysplastic syndromes.

被引：0
|
作者：
Haase, D [1 ]
Schanz, J [1 ]
Wulich, J [1 ]
Schoch, C [1 ]
Freund, M [1 ]
Haferlach, T [1 ]
Wormann, B [1 ]
Staib, P [1 ]
Lentini, G [1 ]
Bartels, H [1 ]
Geissler, RG [1 ]
Germing, U [1 ]
Dorges, U [1 ]
Fonatsch, C [1 ]
Hiddemann, W [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT HEMATOL ONCOL,D-37075 GOTTINGEN,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2232 / 2232
页数：1
相关论文
共 50 条
  • [21] Apoptosis in myelodysplastic syndromes.
    Pearsall, CP
    Kroft, S
    Ross, C
    Schnitzer, B
    Singleton, TP
    LABORATORY INVESTIGATION, 1997, 76 (01) : 767 - 767
  • [22] Megakaryopoiesis in myelodysplastic syndromes.
    Brereton, ML
    Adams, JA
    Briggs, M
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 63 - 63
  • [23] Statins reduce mortality of patients with myelodysplastic syndromes.
    Afzal, Amber
    Fiala, Mark A.
    Jacoby, Meagan
    Walter, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Circulating dendritic cells of the patients with myelodysplastic syndromes.
    Shao, Zonghong
    Wang, Huaquan
    Xing, Limin
    Fu, Rong
    Tu, Fengmei
    BLOOD, 2007, 110 (11) : 221B - 221B
  • [25] Delayed responses to thalidomide in patients with myelodysplastic syndromes.
    Lisak, LA
    Little, L
    Dean, L
    Ekbal, M
    duRandt, M
    Hussain, M
    Kaistha, V
    Raza, A
    BLOOD, 2000, 96 (11) : 261B - 261B
  • [26] Biologic characteristics of patients with hypocellular myelodysplastic syndromes.
    Goyal, R
    Qawi, H
    Ali, SI
    Dar, S
    Mundle, S
    Ahmed, B
    Quadri, M
    Naseer, OB
    Andrews, C
    Shetty, V
    Mativi, B
    Altampallam, K
    Lisak, L
    Loew, J
    Venugopal, P
    Gezer, S
    Robin, E
    Rifkin, S
    Raza, A
    BLOOD, 1998, 92 (10) : 629A - 629A
  • [27] Abnormal lipid profiles in patients with myelodysplastic syndromes.
    Allampallam, K
    Dutt, D
    Nair, C
    Shetty, V
    Mundle, S
    Lisak, L
    Andrews, C
    Ahmed, B
    Mazzone, L
    Zorat, F
    Borok, R
    Muzammil, M
    Akber, A
    Gundroo, A
    Ansaarie, I
    Raza, A
    BLOOD, 1999, 94 (10) : 282B - 282B
  • [28] Chronic hepatitis C as an adverse prognostic factor in myelodysplastic syndromes.
    Thibaud, Santiago
    Kaner, Justin D.
    Shastri, Aditi
    Budhathoki, Anjali
    Sridharan, Ashwin
    Goel, Swati
    Mantzaris, Ioannis
    Janakiram, Murali
    Kornblum, Noah Saul
    Braunschweig, Ira
    Verma, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution
    Paolo Bernasconi
    Catherine Klersy
    Marina Boni
    Paola Maria Cavigliano
    Ilaria Giardini
    Barbara Rocca
    Rita Zappatore
    Irene Dambruoso
    Celeste Calvello
    Marilena Caresana
    Mario Lazzarino
    Annals of Hematology, 2010, 89 : 545 - 551
  • [30] Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution
    Bernasconi, Paolo
    Klersy, Catherine
    Boni, Marina
    Cavigliano, Paola Maria
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Dambruoso, Irene
    Calvello, Celeste
    Caresana, Marilena
    Lazzarino, Mario
    ANNALS OF HEMATOLOGY, 2010, 89 (06) : 545 - 551
12345